港股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

劑泰科技-P

17.850

+1.86011.63%

成交量：1,570.90萬

成交額：2.66億

市值：211.17億

市盈率：-32.81

高：18.000

開：16.300

低：15.800

收：15.990

52周最高：29.980

52周最低：9.460

股本：11.83億

香港流通股本：10.83億

量比：2.51

換手率：1.45%

股息：- -

股息率：- -

每股收益(LYR):-0.544

淨資產收益率：--

總資產收益率：-20.01%

市淨率：5.99

市盈率(LYR):-32.81

市銷率: 70.03

資料載入中...

總覽公司新聞資訊公告

劑泰科技－Ｐ(07666)股價顯著上升11.007%，現價港幣$17.75

阿斯达克财经

異動解讀｜劑泰科技-P盤中上漲5.69%，中報業績爆發疊加AI製藥政策共振

港股異動 | mRNA概念股漲幅居前康希諾生物(06185)升逾17% 莫德納mRNA新抗原療法將亮相ESMO大會

劑泰科技-P2026年中期營收1.54億元，經調整後淨虧損0.51億元

異動解讀｜劑泰科技-P盤中下跌6.21%，報16.3港元

港股異動 | 劑泰科技-P(07666)再升逾6% 跨賽道巨頭佈局AI4S製藥 NanoForge商業化成果迎集中釋放期

港股異動 | 劑泰科技-P(07666.HK)再升逾6% 跨賽道巨頭佈局AI4S製藥 NanoForge商業化成果迎集中釋放期

生物醫藥板塊強勢勁方醫藥-B（02595）漲8.01% 機構指醫藥工業「十五五」規劃有標誌性意義

異動解讀｜劑泰科技-P盤中上漲6.85%，CEO演講強調Biological AI數據壁壘疊加十五五規劃持續催化

劑泰科技-P盤中升逾7% Biological AI的核心競爭力為真實實驗數據

港股異動 | 劑泰科技-P(07666.HK)早盤漲近7% Biological AI的核心競爭力為真實實驗數據

異動解讀｜劑泰科技-P盤中上漲5.15%，十五五規劃與mRNA合資平台等多重利好持續催化

港股異動 | 劑泰科技-P(07666)再升逾9% 多重共振帶動AI製藥上行公司AI+遞送平台價值逐步顯現

異動解讀｜劑泰科技-P盤中上漲5.52%，十五五規劃落地疊加mRNA合資平台消息持續催化

Tempus大漲之後，德適科技(02526)的AI4S價值正在被重新發現

港股午評|恒生指數早盤漲0.67% AI製藥板塊大漲

AI製藥概念股早盤集體走高劑泰科技-P漲逾13%英硅智能漲逾11%

港股異動 | 生物醫藥股悉數走高十部門印發醫藥十五五規劃機構看好醫藥迎「Claude」時刻

港股異動 | AI製藥進入戰略入局階段劑泰科技-P(07666.HK)升逾11%領升板塊英硅智能(03696.HK)升逾6%

異動解讀｜劑泰科技-P盤中上漲8.56%，攜手昭衍生物打造mRNA藥物研發平台消息持續發酵

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/stock/07666/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"07666","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"07666\",,,,,undefined,":{"symbol":"07666","market":"HK","secType":"STK","nameCN":"劑泰科技-P","latestPrice":17.85,"timestamp":1790755707007,"preClose":15.99,"halted":0,"volume":15709000,"delay":0,"changeRate":0.11632270168855542,"floatShares":1083000000,"shares":1183000000,"eps":-0.544063057183209,"marketStatus":"未開盤","change":1.86,"latestTime":"09-30 16:08:27","open":16.3,"high":18,"low":15.8,"amount":265977370,"amplitude":0.137586,"askPrice":17.85,"askSize":31500,"bidPrice":17.79,"bidSize":12000,"shortable":3,"etf":0,"ttmEps":-0.40181737151824237,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1790904600000},"marketStatusCode":0,"adr":0,"listingDate":1778601600000,"exchange":"SEHK","adjPreClose":15.99,"openAndCloseTimeList":[[1790731800000,1790740800000],[1790744400000,1790755200000]],"volumeRatio":2.510154709540251,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"07666\",,,,,undefined,":{"symbol":"07666","floatShares":1083000000,"roa":"-20.01%","roe":"--","lyrEps":-0.544063,"volumeRatio":2.510154709540251,"shares":1183000000,"dividePrice":0,"high":18,"amplitude":0.137586,"preClose":15.99,"low":15.8,"week52Low":9.46,"pbRate":"5.99","psRate":"70.03","week52High":29.98,"institutionHeld":0,"latestPrice":17.85,"committee":-0.448276,"eps":-0.5440715949877597,"divideRate":0,"volume":15709000,"delay":0,"ttmEps":-0.40182367710752614,"open":16.3,"prevYearClose":10.5,"prevWeekClose":15.61,"prevMonthClose":17.85,"prevQuarterClose":17.85,"fiveDayClose":17.38,"twentyDayClose":12.3,"sixtyDayClose":13},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/07666\",params:#limit:5,,,undefined,":[{"date":"2026-08-25","symbol":"07666","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787621400000,"name":null,"time":"","dateTimestamp":1787587200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"07666\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"07666\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":3,"updateTime":1789056000000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/07666\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"07666","date":"2026-09-30","current":-44.43112,"percent":0.061856,"low":-64.32629,"twenty":-44.144401,"median":-36.419402,"eighty":-30.601435,"high":-25.115126,"avg":-37.409019,"sd":8.278369,"marketCap":21111156622},"quantilePoints":[{"date":"2026-05-15","current":-55.2918,"twenty":-62.155958,"median":-58.000435,"eighty":-43.892829,"marketCap":25009550545},{"date":"2026-05-22","current":-43.108917,"twenty":-60.122045,"median":-51.319082,"eighty":-42.587932,"marketCap":19454433788},{"date":"2026-05-29","current":-37.615042,"twenty":-57.955137,"median":-43.960548,"eighty":-41.311685,"marketCap":17034154703},{"date":"2026-06-05","current":-35.730788,"twenty":-53.702713,"median":-41.754744,"eighty":-37.805412,"marketCap":16204344731},{"date":"2026-06-12","current":-33.542538,"twenty":-49.179944,"median":-39.902739,"eighty":-33.466041,"marketCap":15201657681},{"date":"2026-06-18","current":-36.557324,"twenty":-45.569099,"median":-38.090968,"eighty":-33.980188,"marketCap":16607724578},{"date":"2026-06-26","current":-33.269555,"twenty":-43.790222,"median":-37.525599,"eighty":-33.862793,"marketCap":15040305742},{"date":"2026-07-03","current":-35.486471,"twenty":-43.108917,"median":-37.328817,"eighty":-34.391053,"marketCap":16054517930},{"date":"2026-07-10","current":-31.831683,"twenty":-41.806456,"median":-36.56437,"eighty":-33.415043,"marketCap":14383372848},{"date":"2026-07-17","current":-25.695281,"twenty":-41.703031,"median":-36.419402,"eighty":-32.652478,"marketCap":11651915023},{"date":"2026-07-24","current":-28.586248,"twenty":-41.050787,"median":-35.730788,"eighty":-30.94587,"marketCap":12965780812},{"date":"2026-07-31","current":-26.182193,"twenty":-40.132349,"median":-35.165287,"eighty":-28.502242,"marketCap":11897940371},{"date":"2026-08-07","current":-28.884867,"twenty":-39.287405,"median":-34.015343,"eighty":-27.992619,"marketCap":13151600092},{"date":"2026-08-14","current":-31.416679,"twenty":-38.648807,"median":-33.542538,"eighty":-28.093751,"marketCap":14322470963},{"date":"2026-08-21","current":-36.861025,"twenty":-38.587758,"median":-33.478791,"eighty":-28.154822,"marketCap":16841617384},{"date":"2026-08-28","current":-39.81123,"twenty":-38.587758,"median":-34.218497,"eighty":-28.502242,"marketCap":16415846158},{"date":"2026-09-04","current":-39.623229,"twenty":-38.587758,"median":-34.599368,"eighty":-28.723646,"marketCap":16344884287},{"date":"2026-09-11","current":-44.150996,"twenty":-39.829532,"median":-35.165287,"eighty":-28.859493,"marketCap":18237200847},{"date":"2026-09-18","current":-49.755181,"twenty":-41.181236,"median":-35.601303,"eighty":-28.956099,"marketCap":20578942590},{"date":"2026-09-25","current":-44.721922,"twenty":-43.518123,"median":-35.74716,"eighty":-30.09223,"marketCap":18461913438},{"date":"2026-09-30","current":-51.044188,"twenty":-44.144401,"median":-36.419402,"eighty":-30.601435,"marketCap":21111156622}],"updateTime":1790863977105},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"07666\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2671279283","title":"劑泰科技－Ｐ(07666)股價顯著上升11.007%，現價港幣$17.75","url":"https://stock-news.laohu8.com/highlight/detail?id=2671279283","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671279283?lang=zh_tw&edition=fundamental","pubTime":"2026-09-30 15:25","pubTimestamp":1790753100,"startTime":"0","endTime":"0","summary":"[上升股]剂泰科技－Ｐ(07666) 股价在下午03:25比前收市价显著上升11.007%，现股价为港币$17.75。至目前为止，今日最高价为$17.75，而最低价为$15.8。总成交量为1.288千万股，总成交金额为港币$2.16亿。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20260929144024215_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20260929144024215_s.png"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2609301477/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2609301477/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122479318","title":"異動解讀｜劑泰科技-P盤中上漲5.69%，中報業績爆發疊加AI製藥政策共振","url":"https://stock-news.laohu8.com/highlight/detail?id=1122479318","media":"行情直击","labels":["policyRegulatory","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122479318?lang=zh_tw&edition=fundamental","pubTime":"2026-09-30 09:57","pubTimestamp":1790733437,"startTime":"0","endTime":"0","summary":"9月30日，剂泰科技-P盘中上涨5.69%，报16.88港元，成交额5219.07万港元。消息面上，公司近日披露中期业绩，上半年实现营收约1.54亿元，同比大增13,399%，超过去年全年收入47%；经调整净亏损收窄56.4%至约5,110万元。核心平台NanoForge商业化成果进入集中释放期，OpenCGT项目潜在交易总额已超60亿元。此外，公司9月初正式纳入港股通标的，南向资金通道打开；期间先后与绿叶制药、昭衍生物达成战略合作，AI制药亦被纳入医药工业五年计划重点任务，多重利好持续共振。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"剂泰科技盘中上扬，中报爆发叠加AI制药利好","news_tag":"policyRegulatory,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671822138","title":"港股異動 | mRNA概念股漲幅居前 康希諾生物(06185)升逾17% 莫德納mRNA新抗原療法將亮相ESMO大會","url":"https://stock-news.laohu8.com/highlight/detail?id=2671822138","media":"智通财经","labels":["productRelease","conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671822138?lang=zh_tw&edition=fundamental","pubTime":"2026-09-30 09:47","pubTimestamp":1790732842,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，mRNA概念股涨幅居前，截至发稿，康希诺生物涨16.78%，报36.32港元；云顶新耀涨4.29%，报29.18港元；思路迪医药股份涨1.94%，报2.89港元；剂泰科技-P涨1.44%，报16.22港元。值得注意的是，8月25日，康希诺生物与德普世生物签署《mRNA个性化治疗型肿瘤疫苗共同开发战略合作框架协议》。此前在mRNA领域，康希诺生物已布局mRNA 疫苗用于胶质母细胞瘤、横纹肌肉瘤及宫颈癌等适应症的研发。云顶新耀计划在2026年第四季度开展对mRNA疫苗EVM16的 IIT Ib研究。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1502465.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK4588","BK1161","BK1515","BK1191","01952","07666","06185","01244","VXUS","KCAI","BK1574","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141526751","title":"劑泰科技-P2026年中期營收1.54億元，經調整後淨虧損0.51億元","url":"https://stock-news.laohu8.com/highlight/detail?id=1141526751","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141526751?lang=zh_tw&edition=fundamental","pubTime":"2026-09-29 17:23","pubTimestamp":1790673787,"startTime":"0","endTime":"0","summary":"根据公司最新披露的2026年中期报告，剂泰科技-P于报告期内实现来自客户合约的收入约1.54亿元，同比上年同期大幅增长13,399%。本期经调整后净亏损约0.51亿元，相比上年同期的1.17亿元收窄56.4%。报告期内经营活动产生的现金流出净额约1.62亿元，而上年同期为约0.96亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"剂泰科技-P2026年中期营收1.54亿元，经调整后净亏损0.51亿元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120179535","title":"異動解讀｜劑泰科技-P盤中下跌6.21%，報16.3港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1120179535","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120179535?lang=zh_tw&edition=fundamental","pubTime":"2026-09-24 10:13","pubTimestamp":1790216028,"startTime":"0","endTime":"0","summary":"9月24日，剂泰科技-P盘中下跌6.21%，报16.3港元/股，成交额3716.49万港元。剂泰科技-P所在的生物科技行业中，个股普遍承压，康方生物跌3.69%，信达生物跌3.63%，百济神州跌1.47%，荣昌生物跌5.77%，三生制药跌3.76%。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669743721","title":"港股異動 | 劑泰科技-P(07666)再升逾6% 跨賽道巨頭佈局AI4S製藥 NanoForge商業化成果迎集中釋放期","url":"https://stock-news.laohu8.com/highlight/detail?id=2669743721","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669743721?lang=zh_tw&edition=fundamental","pubTime":"2026-09-23 11:15","pubTimestamp":1790133344,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，剂泰科技-P再涨超6%，截至发稿，涨5.01%，报17.62港元，成交额7242.99万港元。东吴证券指出，全球科技巨头正在以不同路径深度嵌入生物医药，AI制药进入战略入局阶段。值得一提的是，上半年，剂泰科技NanoForge商业化成果进入集中释放期，期内营收超过1.54亿元，超过去年全年收入47%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1499700.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["KCAI","VXUS","07666","BK1161","BK1574","BK4585","BK4588","BK1191","01477"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669174377","title":"港股異動 | 劑泰科技-P(07666.HK)再升逾6% 跨賽道巨頭佈局AI4S製藥 NanoForge商業化成果迎集中釋放期","url":"https://stock-news.laohu8.com/highlight/detail?id=2669174377","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669174377?lang=zh_tw&edition=fundamental","pubTime":"2026-09-23 11:15","pubTimestamp":1790133344,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1574","BK1161","07666","BK1191","01477"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669171299","title":"生物醫藥板塊強勢 勁方醫藥-B（02595）漲8.01% 機構指醫藥工業「十五五」規劃有標誌性意義","url":"https://stock-news.laohu8.com/highlight/detail?id=2669171299","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669171299?lang=zh_tw&edition=fundamental","pubTime":"2026-09-23 10:49","pubTimestamp":1790131753,"startTime":"0","endTime":"0","summary":"金吾财讯 | 生物医药板块强势，恒生生物科技、恒生医疗保健指数涨幅均超1%。消息面上，9月18日，工信部、国家发改委等十部门发布医药工业“十五五”规划，对首创新药、创新医疗器械、产业链自主可控与国际化等提出要求，积极鼓励创新药及其产业链，制药装备，精准诊疗产业链。","market":"us","thumbnail":"https://static.szfiu.com/news/20200908/MDgxZGVmMDU5NGQxM2FkZGQzODVkYTY4OWM4NjkxNzk5NzY4NzQ2MDU0.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20200908/MDgxZGVmMDU5NGQxM2FkZGQzODVkYTY4OWM4NjkxNzk5NzY4NzQ2MDU0.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1992289","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595","09939","BK1574","BK4585","BK4588","BK1515","161726","BK1576","01548","02617","BK1583","HK0000306685.HKD","06127","06185","399441","BK4581","BK1141","07666","02410","09966","BK1191","XBI","BK1161","02126","HK0000320264.USD","HK0000320223.HKD","HK0000306701.USD","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125690103","title":"異動解讀｜劑泰科技-P盤中上漲6.85%，CEO演講強調Biological AI數據壁壘疊加十五五規劃持續催化","url":"https://stock-news.laohu8.com/highlight/detail?id=1125690103","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125690103?lang=zh_tw&edition=fundamental","pubTime":"2026-09-23 10:43","pubTimestamp":1790131407,"startTime":"0","endTime":"0","summary":"9月23日，剂泰科技-P盘中上涨6.85%，报17.93港元，成交额5873.57万港元。消息面上，多重利好持续催化。公司联合创始人、CEO赖才达近日受邀发表主旨演讲，强调生物医药AI核心竞争力在于持续获取高质量实验数据并转化为模型能力，提出AI制药\"三层蛋糕\"技术架构。政策端，\"十五五\"规划将AI制药列入医药工业重点任务，明确培育高价值应用场景。业务端，公司此前与昭衍生物签署合资协议设立昭泰智药，打造mRNA药物研发与产业化平台。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"剂泰科技盘中上涨，AI制药利好催化","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669118104","title":"劑泰科技-P盤中升逾7% Biological AI的核心競爭力為真實實驗數據","url":"https://stock-news.laohu8.com/highlight/detail?id=2669118104","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669118104?lang=zh_tw&edition=fundamental","pubTime":"2026-09-22 11:55","pubTimestamp":1790049300,"startTime":"0","endTime":"0","summary":"模拟交易客户端剂泰科技-P盘中涨超7%。截至发稿，股价上涨3.85%，现报17.53港元，成交额8172.92万港元。剂泰科技联合创始人、董事长兼CEO赖才达受邀作《可编程生物学的时代：AI的新前沿》主旨演讲。相比“模型有多大”，赖才达博士更强调另一件事：生物医药AI最终拼的是能否持续获得高质量实验数据，并把这些数据转化成模型能力。据悉，赖才达用一个“三层蛋糕”来描述AI制药的技术架构。最底层也是最厚的第一层，是干实验与湿实验数据平台。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-09-22/doc-inissitf7081721.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["07666","VTHR","QTOC","AIPO","ARTY","CHAT","BK1161","AGIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669190993","title":"港股異動 | 劑泰科技-P(07666.HK)早盤漲近7% Biological AI的核心競爭力為真實實驗數據","url":"https://stock-news.laohu8.com/highlight/detail?id=2669190993","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669190993?lang=zh_tw&edition=fundamental","pubTime":"2026-09-22 10:58","pubTimestamp":1790045932,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160689123","title":"異動解讀｜劑泰科技-P盤中上漲5.15%，十五五規劃與mRNA合資平台等多重利好持續催化","url":"https://stock-news.laohu8.com/highlight/detail?id=1160689123","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160689123?lang=zh_tw&edition=fundamental","pubTime":"2026-09-22 10:23","pubTimestamp":1790043794,"startTime":"0","endTime":"0","summary":"9月22日，剂泰科技-P盘中上涨5.15%，报17.75港元，成交额3881.89万港元，近期累计涨幅显著。消息面上，多重利好持续发酵。政策端，\"十五五\"规划将AI制药列入医药工业重点任务，明确提出\"AI制药高价值应用场景培育\"；业务端，公司近日与昭衍生物签署合资协议设立昭泰智药，打造mRNA药物创新研发与产业化制造平台，NanoForge平台已实现对人体内8个关键器官与组织的靶向递送。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"剂泰科技盘中上涨，AI制药多重利好催化","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669813957","title":"港股異動 | 劑泰科技-P(07666)再升逾9% 多重共振帶動AI製藥上行 公司AI+遞送平台價值逐步顯現","url":"https://stock-news.laohu8.com/highlight/detail?id=2669813957","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669813957?lang=zh_tw&edition=fundamental","pubTime":"2026-09-21 10:06","pubTimestamp":1789956363,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，剂泰科技-P再涨超9%，近三个交易日累涨超35%。这份纲领性文件将AI制药列入医药工业五年计划的重点任务，明确提出“深化人工智能赋能升级”，并专门列出“AI制药高价值应用场景培育”专栏。当前，AI制药正处于行业外新增资本与产业内研发预算双轮驱动的上行通道。行业内，礼来等MNC持续扩大AI在药物发现、临床前及研发流程中的应用；Anthropic则设立生物实验室，推进AI药物研发项目。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1498528.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","BK4585","AIPO","CHAT","ARTY","01477","QTOC","07666","BK1191","KCAI","AGIX","VXUS","BK1574","BK1161","VTHR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103868237","title":"異動解讀｜劑泰科技-P盤中上漲5.52%，十五五規劃落地疊加mRNA合資平台消息持續催化","url":"https://stock-news.laohu8.com/highlight/detail?id=1103868237","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103868237?lang=zh_tw&edition=fundamental","pubTime":"2026-09-21 09:35","pubTimestamp":1789954500,"startTime":"0","endTime":"0","summary":"9月21日，剂泰科技-P盘中上涨5.52%，报18.0港元，成交额3296.7万港元。消息面上，多重利好持续发酵。政策端，\"十五五\"规划重磅落地，AI医疗概念股集体走强，剂泰科技上一交易日曾涨超14%领涨板块。根据协议，剂泰科技在上游提供AI驱动的mRNA序列设计与纳米递送能力，NanoForge平台已实现对人体内8个关键器官与组织的靶向递送。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"剂泰科技盘中上涨，AI医疗与mRNA平台双催化","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668957971","title":"Tempus大漲之後，德適科技(02526)的AI4S價值正在被重新發現","url":"https://stock-news.laohu8.com/highlight/detail?id=2668957971","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668957971?lang=zh_tw&edition=fundamental","pubTime":"2026-09-19 09:12","pubTimestamp":1789780357,"startTime":"0","endTime":"0","summary":"同日德适收涨0.39%。Tempus的经营数据给出了线索。沿着这条线研究德适，可以看到一家更接近AI4S本质的公司。iMedLoop于7月上线，晚于上半年报告期。德适正在构建AI4S看重的“发现问题—组织数据—训练模型—验证效果—重新交付”闭环。Tempus的行情提醒市场，高质量医学数据进入真实工作流并产生商业回报，才更有基础获得更高定价。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1498329.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02526","07666","BK1161","BK1100","BK1141","03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668191239","title":"港股午評|恒生指數早盤漲0.67%     AI製藥板塊大漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2668191239","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668191239?lang=zh_tw&edition=fundamental","pubTime":"2026-09-18 12:00","pubTimestamp":1789704004,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，港股恒生指数涨0.67%，涨164点，报24768点；恒生科技指数涨1.74%。港股早盘成交1070亿港元。十部门印发医药十五五规划，机构看好医药迎“Claude”时刻。AI制药进入战略入局阶段。曦智科技-P涨超17%。天数智芯涨超13%，公司有望持续受益AI资本开支的增长及算力自主可控浪潮。MINIMAX-W涨13%，旗下多款产品通过Singtel AI Pass纳入配套订阅计划。俊知集团涨超10%，收购青海中利光纤技术有望打开AI算力相关光纤产品增量空间。大股东解禁期满。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1497792.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1197","BK1237","03033","BK1193","07552","LU1235295612.USD","LU0128522157.USD","BK1141","HHImain","01787","LU0672654166.SGD","IE0003895053.USD","LU0264606111.USD","LNVGY","LU1267930227.SGD","BK1607","02701","LU0244354667.USD","BK1576","HK0000320223.HKD","03696","BK1617","600547","00100","09067","BK1592","LU0572939691.SGD","LU1831875114.USD","06658","02670","03419","LU1808992512.USD","BK1161","LU1046422090.SGD","BK1583","BK1198","02837","BK1117","07630","03417","02228","03088","03115","00992","02142","IE0032431581.USD","LU1366334578.USD","603127","02800","03423","LU0417516902.SGD","LU0572940350.SGD","300077","LU0181495838.USD","82800","83115","LU0049112450.USD","LU0972618739.USD","LU0862451753.SGD","LU0326950275.SGD","LU0828237940.HKD","IE0034224299.USD","IE00B0JY6N72.USD","LU1188198961.HKD","BK1163","06127","LU0862451837.USD","07226","LU0370786039.SGD","HK0000320264.USD","TCHI","LU0029875118.USD","01300","LU0543330483.HKD","BK1506","LU0348825331.USD","LU0348827113.USD","09088","LU0791590937.USD","01818","LU0140636845.USD","LU0791591158.USD","07500","LU2242644610.SGD","LU0048580855.USD","03067","01879","MCHmain","07200","HK0000306701.USD","07666","02656","09115","BK1149","09903","BK1574","BK1544","03037","HSTECH","LU0890818403.SGD","LU0320764755.SGD","LU0128525689.USD","07300","BK1526","LU1366334651.USD","BK1183","HSI","LU0463099449.HKD","80992","02833","HK0000306685.HKD","LU0052756011.USD","03032","LU1785774172.SGD","513600","LU0561508036.HKD","LU0310800965.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668891996","title":"AI製藥概念股早盤集體走高 劑泰科技-P漲逾13%英硅智能漲逾11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2668891996","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668891996?lang=zh_tw&edition=fundamental","pubTime":"2026-09-18 10:11","pubTimestamp":1789697460,"startTime":"0","endTime":"0","summary":"热点栏目自选股\n数据中心\n行情中心\n资金流向\n模拟交易客户端AI制药概念股早盘集体走高，截至发稿，剂泰科技-P（07666）上涨13.20%，报17.58港元；英硅智能（03696）上涨10.98%，报59.65港元；晶泰控股（02228）上涨8.34%，报7.47港元；金斯瑞生物科技（01548）上涨6.39%，报39.60港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-09-18/doc-inisfazi3502899.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1161","VTHR","BK1191","BK1574","07666","AIPO","CHAT","AGIX","ARTY","01477","QTOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668919445","title":"港股異動 | 生物醫藥股悉數走高 十部門印發醫藥十五五規劃 機構看好醫藥迎「Claude」時刻","url":"https://stock-news.laohu8.com/highlight/detail?id=2668919445","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668919445?lang=zh_tw&edition=fundamental","pubTime":"2026-09-18 10:04","pubTimestamp":1789697085,"startTime":"0","endTime":"0","summary":"消息面上，工信部等十部门联合发布《医药工业发展\"十五五\"规划》，提出到2030年的发展目标：生物医药研发应用稳居世界前列，创新驱动效能充分释放，重点领域关键核心技术实现系统性突破，生物医药产业加速成为国家新兴支柱产业。浙商证券表示，高频迭代短期将会带来验证阶段需求的井喷，但长期来看，高速迭代可能会带来平台能力的提升和泛化，能够持续迭代的发现平台能力提升或是行业的核心，医药行业的Claude也许将要到来。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1497761.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09688","09939","BK4585","KCAI","02142","BK1515","BK1588","VXUS","BK1141","BK1583","399441","06127","161726","BK4581","01672","XBI","07666","BK4588","BK1576","LU2488822045.USD","159938","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668291615","title":"港股異動 | AI製藥進入戰略入局階段 劑泰科技-P(07666.HK)升逾11%領升板塊 英硅智能(03696.HK)升逾6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2668291615","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668291615?lang=zh_tw&edition=fundamental","pubTime":"2026-09-18 09:36","pubTimestamp":1789695405,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1191","01477","03696","BK1141","BK1574","07666","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194789363","title":"異動解讀｜劑泰科技-P盤中上漲8.56%，攜手昭衍生物打造mRNA藥物研發平台消息持續發酵","url":"https://stock-news.laohu8.com/highlight/detail?id=1194789363","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194789363?lang=zh_tw&edition=fundamental","pubTime":"2026-09-18 09:33","pubTimestamp":1789695237,"startTime":"0","endTime":"0","summary":"9月18日，剂泰科技-P盘中上涨8.56%，报17.1港元，成交额2961.84万港元。消息面上，公司近日与昭衍生物正式签署合资协议，共同设立合资公司昭泰智药，携手打造mRNA药物创新研发与产业化制造平台，首个合作项目已启动。根据协议，剂泰科技将在上游提供设计与递送能力，NanoForge已实现对人体内8个关键器官与组织的靶向递送。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"剂泰科技携手昭衍生物，共建mRNA药物平台","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":1,"totalSize":172,"code":"91000000","status":"200"}]}}